SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore (SOC) is seeing extreme volatility as investors weigh the potential for a massive short squeeze against significant regulatory and legal headwinds. The community is sharply divided between those betting on federal support via the Defense Production Act to bypass California's pipeline restrictions and those concerned about the company's precarious financial position and ongoing environmental litigation.

Trump For President

The TRUMP crypto token is seeing heightened volatility and community debate, driven by a recent surge in speculation regarding potential exclusive event access for top holders. While some supporters are aggressively trading the asset on speculation and high-upside narratives, a large segment of the community remains highly critical, frequently labeling the project a grift and focusing on the broader controversies surrounding the Trump family's political and financial activities.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors focus on the potential for a curative outcome in its Phase 3 REGAL trial and the recent expansion of its SLS009 pipeline into front-line AML. The community remains intensely focused on the long-awaited 80th event milestone, with active debates surrounding institutional accumulation, warrant activity, and the company's valuation as a prospective buyout candidate.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO) is trending as investors aggressively position themselves ahead of its first-ever halving event in December and mounting excitement over recent institutional moves, including Grayscales ETF filing. The community is buzzing with long-term bullish sentiment, actively discussing the potential for decentralized AI to disrupt tech giants while sharing strategies for staking on various high-yield subnets within the ecosystem.

PayPay Corp. engages in the development and provision of electronic payment services that include mobile payment. The company was founded on June 15, 2018 and is headquartered in Tokyo, Japan.

PayPay Corp - ADR - Sponsor

PayPay

PayPay (PAYP) is trending as traders analyze its volatile debut following a US IPO that priced below the expected range, with many mistakenly conflating it with the payment giant PayPal. Market participants are actively debating the stock's valuation and long-term potential, creating a sharp divide between those speculating on short-term momentum and those skeptical of IPO hype.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid intensifying investor scrutiny as the company's valuation faces significant downward pressure from broader market volatility, geopolitical instability in the Middle East, and ongoing controversy surrounding its leadership. Community discussions are highly polarized, with vocal critics highlighting operational losses and skepticism regarding the platform's long-term business viability, while a segment of the base maintains strong ideological support despite the stocks recent performance.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing short-term volatility as traders react to reports of a delayed AI model rollout and broader concerns over aggressive capital expenditures. While community sentiment is heavily polarized between skeptics questioning the stock's long-term growth and bullish investors viewing the dip as a prime accumulation opportunity, the active discussion remains centered on the company's competitive positioning in the AI race and its overall fundamental resilience.

Volatility Shares Trust - 2x Ether ETF

Volatility Shares 2x Ether ETF

The Volatility Shares 2x Ether ETF ($ETHU) is trending as traders heavily leverage the recent volatility in the underlying crypto market, with the community actively debating the pros and cons of using 2x leveraged products to play Ethereum's price swings versus holding the spot asset or other crypto-exposed stocks. Market participants are intensely focused on the ETF's rapid price action and the impact of volatility decay, with many debating optimal entry points during recent price pullbacks and speculating on whether the current market conditions favor a breakout or further consolidation.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is currently trending as investors weigh the initial commercial traction of its flagship fibromyalgia treatment, TONMYA, against ongoing concerns regarding share dilution and the company's historical cash burn. While the community is actively debating the significance of recent market access wins and the potential for a short squeeze, sentiment remains sharply divided between those optimistic about long-term institutional accumulation and those frustrated by the stock's persistent downward price action.

BlackRock, Inc. engages in the provision of investment, advisory and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock is currently navigating market volatility driven by significant redemption pressure within its private credit funds, forcing the firm to cap withdrawals for its HPS Corporate Lending Fund. Investors are actively debating whether this signals a broader liquidity crisis in the shadow banking sector or if the firm's robust $14 trillion AUM provides sufficient structural resilience to weather the storm.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prestige Consumer Healthcare Inc. $PBH Shares Sold by Natixis Advisors LLC

Natixis Advisors LLC lessened its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 24.8% in the 3rd quarter, according to the company in its most recent Form 13F...

Citigroup Inc. Sells 16,797 Shares of Prestige Consumer Healthcare Inc. $PBH

Citigroup Inc. cut its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 23.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and...

Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Recommendation of "Hold" by Brokerages

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) has earned an average recommendation of "Hold" from the seven analysts that are currently covering the company, MarketBeat.com reports...

JPMorgan Chase & Co. Grows Stock Holdings in Prestige Consumer Healthcare Inc. $PBH

JPMorgan Chase & Co. boosted its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 30.1% during the third quarter, according to its most recent Form 13F filing with the...

Vanguard Group Inc. Lowers Position in Prestige Consumer Healthcare Inc. $PBH

Vanguard Group Inc. decreased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 2.5% in the 3rd quarter, according to the company in its most recent 13F filing with the...

What is Zacks Research's Estimate for PBH Q1 Earnings?

Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) - Stock analysts at Zacks Research cut their Q1 2027 earnings estimates for Prestige Consumer Healthcare in a research note issued to...

Equities Analysts Offer Predictions for PBH Q4 Earnings

Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) - Equities research analysts at Zacks Research increased their Q4 2026 EPS estimates for Prestige Consumer Healthcare in a research report...

King Luther Capital Management Corp Buys Shares of 36,347 Prestige Consumer Healthcare Inc. $PBH

King Luther Capital Management Corp purchased a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the...

Prestige Consumer Healthcare (NYSE:PBH) Shares Gap Up - Should You Buy?

Prestige Consumer Healthcare (NYSE:PBH) Shares Gap Up - Still a Buy...

Prestige Consumer Healthcare Inc. $PBH Stake Lifted by Heartland Advisors Inc.

Heartland Advisors Inc. grew its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 41.4% in the 3rd quarter, according to the company in its most recent Form 13F...

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$1.39	--	--	N/A
Q3 '25	$1.14	$1.14	-0.39%	MISSED
Q2 '25	$0.97	$1.07	10.35%	BEAT
Q1 '25	$1.00	$0.95	-4.99%	MISSED
Q4 '24	$1.30	$1.32	1.67%	BEAT

PBH
Prestige Consumer Healthcare Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest PBH News

PBHPrestige Consumer Healthcare Inc